Technical Analysis for TTNP - Titan Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 4.00 0.37% 0.01
TTNP closed up 0.37 percent on Friday, November 1, 2024, on 36 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 0.37%
Gapped Down Weakness 0.37%
NR7 Range Contraction -1.11%
NR7-2 Range Contraction -1.11%
Narrow Range Bar Range Contraction -1.11%
Inside Day Range Contraction -1.11%
Wide Bands Range Expansion -1.11%
Oversold Stochastic Weakness -1.11%
New Downtrend Bearish 1.39%

   Recent Intraday Alerts

Alert Time
Down 3% about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
Down 2 % about 21 hours ago
Down 1% 1 day ago
Down 5% 2 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Titan Pharmaceuticals, Inc. Description

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company's ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Organic Compounds Chemical Compounds Parkinson's Disease Opioids Schizophrenia Drug Delivery Chronic Condition Morphinans Drug Delivery Technology Treatment Of Schizophrenia Antipsychotic Atypical Antipsychotics Drug Rehabilitation Psychopathology Buprenorphine Fanapt Iloperidone

Is TTNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.8
52 Week Low 3.565
Average Volume 34,033
200-Day Moving Average 6.23
50-Day Moving Average 5.19
20-Day Moving Average 4.49
10-Day Moving Average 4.08
Average True Range 0.32
RSI (14) 32.89
ADX 27.68
+DI 13.34
-DI 30.34
Chandelier Exit (Long, 3 ATRs) 4.50
Chandelier Exit (Short, 3 ATRs) 4.53
Upper Bollinger Bands 5.38
Lower Bollinger Band 3.60
Percent B (%b) 0.23
BandWidth 39.73
MACD Line -0.38
MACD Signal Line -0.36
MACD Histogram -0.0213
Fundamentals Value
Market Cap 3.02 Million
Num Shares 753 Thousand
EPS -8.20
Price-to-Earnings (P/E) Ratio -0.49
Price-to-Sales 17.93
Price-to-Book 0.67
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.34
Resistance 3 (R3) 4.30 4.15 4.29
Resistance 2 (R2) 4.15 4.07 4.17 4.27
Resistance 1 (R1) 4.08 4.02 4.12 4.12 4.25
Pivot Point 3.93 3.93 3.95 3.95 3.93
Support 1 (S1) 3.85 3.84 3.89 3.89 3.76
Support 2 (S2) 3.71 3.79 3.72 3.74
Support 3 (S3) 3.63 3.71 3.72
Support 4 (S4) 3.67